Microdroplet and splatter contamination during phacoemulsification in COVID-19 era
3 June 2021
| Ivan Yip
|
EYE - Cataract, EYE - Refractive
|
COVID-19, SARS-CoV-2, aerosol-generating procedure, microdroplet generating procedure, phacoemulsification cataract surgery
Half a millilitre of fluorescein was incorporated into 400ml of balanced salt solution to identify microdroplet and splatter from phacoemulsification to simulate possible COVID-19 contamination. Five porcine eyes were mounted to an ophthalmic mannequin head and two surgeons (height 189cm,...
Biometric changes in phakic eyes over time
3 June 2021
| Su Young
|
EYE - Cataract, EYE - Refractive
|
Biometry, anatomy, cataract surgery, management, surgical planning
This was a single-centre retrospective cohort study of patients who attended a ‘two-stop’ preassessment clinic for consideration of cataract surgery between November 2002 and March 2015. Four biometric measurements were recorded: axial length, horizontal (K1) readings, vertical (K2) readings and...
Wet AMD outcomes post cataract surgery
3 June 2021
| Kareem Waleed Alsaffarini
|
EYE - Cataract, EYE - Refractive
|
age-related cataract, antivascular endothelial growth factor, cataract surgery, wet age-related macular degeneration
The authors present the findings of a retrospective study looking at the progression of wet age-related macular degeneration (AMD) in patients who underwent cataract surgery. They recruited a series of 111 patients of which 38 were men and 73 were...
Topical nonsteroidal ant-inflammatory drugs (NSAIDs) in patients undergoing cataract surgery
4 February 2021
| Kurt Spiteri Cornish
|
EYE - Cataract, EYE - Refractive
|
Postoperative inflammation, cataract surgery, diclofenac, laser flare meter, nepafenac
Inflammation is a major risk factor for the development of cystoid macular oedema (CMO) after cataract surgery, leading to breakdown of the blood-retina barrier. There is a correlation between severity of CMO and level of postoperative inflammation. Laser flare meter...
Practical application of cataract risk stratification
5 August 2020
| Ivan Yip
|
EYE - Cataract, EYE - Refractive
|
cataract surgery, surgical complication, vocational training
This study assessed the practicability of a risk stratification system, the New Zealand Cataract Risk Stratification (NZCRS) in a major teaching hospital. The scoring system was as follows: three points for Dense cataract, pseudoexfoliation (PXF), phacodonesis, previous vitrectomy and only...
Cystoid macular oedema following cataract surgery
1 October 2019
| Ivan Yip
|
EYE - Cataract, EYE - Refractive
|
NSAIDs, cataract, cataract surgery, corticosteroids, cystoid macular oedema
This review covers the history, incidence, diagnosis, risk factors, pathophysiology and medical management of postoperative macular oedema (PCMO), with a particular emphasis on key contemporary studies and novel observations. The authors revisit the incidence of well-established risk factors including intraoperative...
Effect of cataract surgery on inflammation control and vision in uveitis patients
1 June 2019
| Ivan Yip
|
EYE - Cataract, EYE - Refractive
|
cataract surgery, phacoemulsification, uveitis, vision impairment
This retrospective longitudinal study from Moorfields, London, UK compared uveitis recurrence rates and vision loss in 309 eyes of uveitis patients post cataract surgery to 300 control uveitis patients. Cataract is a common complication associated with uveitis and leads to...
Diclofenac versus Bromfenac after cataract surgery
1 April 2019
| Kurt Spiteri Cornish
|
EYE - Cataract, EYE - Refractive
|
Non-steroidal anti-inflammatory drugs, bromfenac, cataract surgery, diclofenac, intraocular inflammation
Non-steroidal anti-inflammatory drugs (NSAIDs) are commonly used after cataract surgery to reduce inflammation and cystoid macular oedema (CMO). Diclofenac 0.1% is used three to five times daily for 28 days and Bromfenac 0.09% twice daily for 14 days postoperatively. The...
Temporal versus nasal clear corneal incisions
1 April 2019
| Jonathan Chan
|
EYE - Cataract, EYE - Refractive
|
cataract surgery, corneal shape change, nasal clear corneal incision, temporal clear corneal incision
This is a prospective randomised study of 100 patients’ left eye having undergone phacoemulsification either by a 2.4mm nasal clear corneal incision (CCI) group or temporal CCI group. The corneal astigmatic changes were compared between groups by power vector analysis,...
Should intravitreal steroids be used in the initial treatment of post-op endophthalmitis?
1 October 2018
| Eulee Seow
|
EYE - Cataract, EYE - Refractive
|
adjuvant intravitreal dexamethasone, cataract surgery, postoperative bacterial endophthalmitis, randomized controlled trial
Endophthalmitis following cataract surgery is one of the most feared complications, and can have significant impact on the visual outcomes of patients. The role of steroids in the management of endopthalmitis is controversial. The aim of this paper was to...
Intraocular surgical training – is there any inter-procedural transfer of skills?
1 June 2018
| Eulee Seow
|
EYE - Cataract, EYE - Refractive
|
assessment/formative feedback, cataract surgery, simulation-based training, vitreoretinal surgery
Cataract surgery is the most commonly performed surgery during ophthalmology training. This study aims to investigate how experience in simulated cataract surgery impacts and transfers to the learning curves for novices in vitreoretinal surgery. Twelve ophthalmology residents without previous experience...
Health-related quality of life after cataract surgery
1 June 2016
| Bheemanagouda Patil
|
EYE - Cataract, EYE - Refractive
|
cataract, cataract surgery, quality of life, quality-adjusted life years
This prospective study evaluates the impact of cataract surgery on subjects’ health-related quality of life (HRQoL) measured with a 15-dimension generic instrument, the 15D. The HRQoL of cataract subjects was compared with that of an age- and gender-standardised sample of...
